Accelerate Diagnostics, INC Schedule 13G passive stakes
Filed when an investor crosses five percent without intending to seek control — the passive counterpart to a 13D.
SCHEDULE 13G/A: Armistice Capital and Steven Boyd Disclose 7.45% Passive Stake in Accelerate Diagnostics
Armistice Capital, LLC and Steven Boyd have disclosed a 7.45% passive ownership stake in Accelerate Diagnostics, Inc., holding 1,879,227 shares of common stock.
Armistice Capital, LLC and Steven Boyd have disclosed a beneficial ownership of 8.25% in Accelerate Diagnostics, Inc., totaling 2,078,000 shares of common stock.
Griffin Asset Management, LLC has filed an amended Schedule 13G, reporting a 4.0% passive beneficial ownership stake in Accelerate Diagnostics, Inc. as of December 31, 2024.